Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for upcoming IPOs.
There were no new IPO filings in Asia but there will still be a handful of listing trickling in as we approach the end of Q2.
Starting in Hong Kong, Hansoh Pharmaceutical (3692 HK), launched its bookbuild on Thursday with a strong line up of cornerstone investors. The company had also announced a positive development just before it launched its IPO. Ke Yan, CFA, FRM discussed the company's valuation and the license-in from Viela Bio in:
Other IPOs that have opened their books this week include China East Education (667 HK), Tai Hing (1719303D HK), China Tobacco International (HK) (6055 HK), and CSSC (Hong Kong) Shipping Co Ltd (3877 HK).
Beyond that, ESR Cayman (ESR HK) will be opening its book next week. For early thoughts on valuation, Sumeet Singh has covered the company extensively in:
In the U.S, GSX Techedu (GSX US) will debut next week and we have covered the IPO in:
Other markets have been fairly quiet. In Australia, there are news on Home Consortium and Education Center of Australia planning for their IPO while India will likely see more activity after elections being out of the way.
Our overall accuracy rate is 72.4% for IPOs and 63.9% for Placements
(Performance measurement criteria is explained at the end of the note)
Below is a snippet of our IPO tool showing upcoming events for the next week. The IPO tool is designed to provide readers with timely information on all IPO related events (Book open/closing, listing, initiation, lock-up expiry, etc) for all the deals that we have worked on. You can access the tool here or through the tools menu.
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.